Considerations in the development of circulating tumor cell technology for clinical use

Considerations in the development of circulating tumor cell technology for clinical use

<p>Abstract</p> <p>This manuscript summarizes current thinking on the value and promise of evolving circulating tumor cell (CTC) technologies for cancer patient diagnosis, prognosis, and response to therapy, as well as accelerating oncologic drug development. Moving forward require...

Full description

Bibliographic Details
Main Authors: Parkinson David R, Dracopoli Nicholas, Petty Brenda, Compton Carolyn, Cristofanilli Massimo, Deisseroth Albert, Hayes Daniel F, Kapke Gordon, Kumar Prasanna, Lee Jerry SH, Liu Minetta C, McCormack Robert, Mikulski Stanislaw, Nagahara Larry, Pantel Klaus, Pearson-White Sonia, Punnoose Elizabeth A, Roadcap Lori T, Schade Andrew E, Scher Howard I, Sigman Caroline C, Kelloff Gary J
Format: Article
Language:English
Published: BMC 2012-07-01
Series:Journal of Translational Medicine
Subjects:
Circulating tumor cells
Prognostic biomarker
Predictive biomarker
Analytical validation
Clinical validation
Biomarker qualification
Oncologic drug development
Online Access:http://www.translational-medicine.com/content/10/1/138

Internet

http://www.translational-medicine.com/content/10/1/138

Similar Items